Cosmos Health Inc. (COSM) News
Track canonical SquawkNews coverage tagged to COSM, Cosmos Health Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 38 indexed stories across 25 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Cosmos Health Inc. (COSM) Unit Hits $60M Run-Rate, Eyes $100M+ Capacity
Cosmos Health said CosmoFarm delivered over $15M revenue in Q2 2026, an annualized run-rate above $60M, and is adding robotics and AI to support capacity for annualized revenue above $100M.Material DetailsContext by AI A
CENTRAL_BANK | Sep 29, 2026, 01:38 PM UTC
L
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
CHICAGO, IL / / September 29, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on its wholly owned pharmac
NEWS | Sep 29, 2026, 01:38 PM UTC
H
Cosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M
Record Q2 2026 revenue of over $15 million, an annualized run-rate of over $60 million, at wholly owned subsidiary CosmoFarm Revenue up 4.3x under Cosmos Health ownership - from ~$14 million in fiscal 2017, the last full
LIVE | Sep 29, 2026, 01:34 PM UTC
M
CosmoFarm annualized revenue tops $60M at Cosmos Health
Cosmos Health said its CosmoFarm reached record annualized revenue above $60 million, up 4.3x under Cosmos Health ownership. The company added that robotics and AI are building capacity to support over $100 million in an
EQUITY | Sep 29, 2026, 01:30 PM UTC
L
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
CHICAGO, IL / / September 28, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that the contract manufacturing ("CM
NEWS | Sep 28, 2026, 12:08 PM UTC
L
Cosmos Health Inc. (NASDAQ:COSM) Adds 5.2M Units; Orderbook Hits 32.7M, Up 31% Since June
Cosmos Health announced five-year manufacturing deals with Target Pharma totaling ~5.2M units, adding ~1.04M units annually and lifting Cana’s orderbook to >32.7M units, up 31% since June 2026.Material DetailsContext by
NEWS | Sep 15, 2026, 02:33 PM UTC
L
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
CHICAGO, IL / / September 15, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Ca
NEWS | Sep 15, 2026, 02:32 PM UTC
L
COSM - Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
COSM - Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
NEWS | Sep 15, 2026, 02:30 PM UTC
L
COSM - Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
COSM - Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
NEWS | Sep 14, 2026, 07:59 PM UTC
L
Cosmos Health receives first UK orders for veterinary antimicrobial line
Cosmos Health (NASDAQ:COSM) said it has received its first orders for its veterinary antimicrobial line, marketed under C-ScrubVet in the UK.
EQUITY | Sep 09, 2026, 01:31 PM UTC
M
Cosmos Health launches C-ScrubVet in the UK
Cosmos Health (COSM) launched C-ScrubVet in the UK, moving into the $69 billion global animal health market.
EQUITY | Sep 09, 2026, 01:30 PM UTC
L
Cosmos Health reaffirms 2029 guidance
Cosmos Health Inc says it is reaffirming its 2029 guidance.
EQUITY | Sep 03, 2026, 02:49 PM UTC
L
Cosmos Health reaffirms FY 2029 guidance and profit outlook
Cosmos Health reaffirms FY 2029 guidance, expecting $200.60M revenue, $71.20M gross profit, $31M net income and $44.20M adjusted EBITDA.
EARNINGS | Sep 03, 2026, 01:34 PM UTC
L
COSM - Cosmos Health: A Company Transformed — 2026 Year-to-Date
COSM - Cosmos Health: A Company Transformed — 2026 Year-to-Date
EQUITY | Sep 03, 2026, 01:30 PM UTC
M
Cosmos Health retires $8M ATW convertible note early
Cosmos Health retired a $8M ATW convertible note one year ahead of maturity, eliminating further dilution from conversions and strengthening its balance sheet.
EQUITY | Aug 28, 2026, 01:37 PM UTC
L
Cosmos Health retires $8M ATW convertible note one year early
Cosmos Health will retire a $8M ATW convertible note one year ahead of maturity, eliminating further dilution from conversions.
EQUITY | Aug 28, 2026, 01:30 PM UTC
L
COSM - Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and An
COSM - Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
EQUITY | Aug 24, 2026, 07:40 PM UTC
L
Cosmos Health enters Saudi Arabia via exclusive distribution deal
Cosmos Health says it has entered Saudi Arabia through an exclusive distribution agreement with Innova Healthcare and secured an initial purchase order for 126,000 Sky Premium Life units.
MNA | Aug 20, 2026, 01:30 PM UTC
L
Cosmos Health reports Q2 2026 record revenue; $5M buyback underway
Cosmos Health (COSM) reports Q2 2026 revenue of $19.0M and H1 revenue of $36.9M, up 29% and 30%, with Q2 adjusted gross profit up 58% and liabilities down 13%.
EARNINGS | Aug 19, 2026, 01:00 PM UTC
L
Cosmos Health reports Q2 gross profit of $1.51M, revenue $18.99M
Cosmos Health reports second-quarter gross profit of $1.51 million and revenue of $18.99 million.
EQUITY | Aug 19, 2026, 01:00 PM UTC
L
Cosmos Health CEO Buys 349,825 Shares
CEO buys shares at $0.2
FX | Jul 31, 2026, 03:53 PM UTC
L
Cosmos Health CEO Buys 766,284 Shares
CEO buys shares at $0.183
FX | Jul 30, 2026, 03:10 PM UTC
L
COSM Cosmos health expands Pharma cell partnership in Albania with annualized orders projected to exceed 54,000 units
COSM Cosmos health expands Pharma cell partnership in Albania with annualized orders projected to exceed 54,000 units
EQUITY | Jul 20, 2026, 07:46 PM UTC
L
COSM Cosmos health Inc: share buyback expands to 5.11M shares; continues open market repurchases
COSM Cosmos health Inc: share buyback expands to 5.11M shares; continues open market repurchases
EQUITY | Jul 17, 2026, 06:56 PM UTC
L
COSM Cosmos health share buyback surpasses $1M, reaching 4.84M shares; continues open market repurchases
COSM Cosmos health share buyback surpasses $1M, reaching 4.84M shares; continues open market repurchases
EQUITY | Jul 16, 2026, 05:15 PM UTC
L
Cosmos Health repurchases additional 215,000 common shares in open market
Cosmos Health repurchases additional 215,000 common shares in open market
EQUITY | Jul 13, 2026, 07:03 PM UTC
H
Cosmos Health reports preliminary Q2 revenue $19.4M
The company said, "Based on preliminary results, the Company expects to report second-quarter 2026 revenue of approximately $19.4 million, up approximately 31.5% from $14.75 million in Q2 2025, and first-half revenue of
EQUITY | Jul 07, 2026, 01:32 PM UTC
L
Cosmos Health Expands Share Buyback to 3.4 Million Shares
() -- Cosmos Health (COSM) said Thursday it repurchased an additional 770,000 common shares at an average price of about $0.1956 each, bringing total repurchases under its existing buyback program to 3.42 million shares.
EQUITY | Jul 02, 2026, 07:27 PM UTC
L
Cosmos Health Repurchases Additional 770K Shares At Average Price Of ~$0.1956 Per Share
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ: COSM ), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stoc
REGULATION | Jul 02, 2026, 06:20 PM UTC
L
Cosmos Health Authorizes Share Repurchase Plan Up To $5M Of The Company's Common Stock
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ: COSM ), a diversified, vertically integrated global healthcare group, today announced that its Board of Directors has authorized a share repurchase program o
REGULATION | Jun 30, 2026, 03:57 PM UTC
L
COSM Sees Vol
COSM is experiencing some volatility
EQUITY | Jun 26, 2026, 04:32 PM UTC
M
COSM Signs Distribution Deal
Cosmos Health signs distribution agreement with IMC, owner of Qatar's largest pharmacy chain, and secures initial purchase order of 31,000 Sky Premium Life units
EQUITY | Jun 26, 2026, 04:30 PM UTC
M
COSM Advances Patent
Cosmos Health advances international patent application for its proprietary hydrogel weight management platform
EQUITY | Jun 25, 2026, 07:31 PM UTC
H
COSM Gains Traction
Cosmos Health's C-Sept PRO gains strong traction across leading Greek public and private hospital groups, with annualized sales poised to exceed $1.3 million at approximately 72% gross margin
EARNINGS | Jun 24, 2026, 07:37 PM UTC
H
COSM Gains Traction
Cosmos Health's C-Sept PRO gains strong traction across leading Greek public and private hospital groups, with annualized sales poised to exceed $1.3 million at approximately 72% gross margin
EARNINGS | Jun 24, 2026, 07:37 PM UTC
M
COSM Deploys AI Call Center
Cosmos Health signs agreement to deploy AI-powered call center to optimize operations
EQUITY | Jun 23, 2026, 07:35 PM UTC
H
COSM Expands Contract Manufacturing
Cosmos Health builds contract manufacturing orderbook to over 25 million units, positioned to generate over $10 million in recurring annual profit
EARNINGS | Jun 22, 2026, 02:30 PM UTC
H
COSM Reports Record Q2 Revenue
CosmoFarm delivers record Q2 2026 revenue of over $15M, representing a $60+ million annualized run-rate
EARNINGS | Jun 18, 2026, 07:34 PM UTC